VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 20 filers reported holding VASCULAR BIOGENICS LTD in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $39,000 | +11.4% | 29,783 | +30.4% | 0.02% | +13.3% |
Q1 2019 | $35,000 | -91.4% | 22,834 | -65.7% | 0.02% | -75.0% |
Q3 2017 | $406,000 | -8.8% | 66,564 | -33.4% | 0.06% | +13.2% |
Q2 2017 | $445,000 | -33.7% | 99,935 | -18.0% | 0.05% | -19.7% |
Q1 2017 | $671,000 | +19.6% | 121,935 | +5.4% | 0.07% | +40.4% |
Q4 2016 | $561,000 | +35.5% | 115,735 | +46.0% | 0.05% | +20.5% |
Q3 2016 | $414,000 | +170.6% | 79,253 | +138.7% | 0.04% | +85.7% |
Q2 2016 | $153,000 | +37.8% | 33,200 | +4.1% | 0.02% | +40.0% |
Q1 2016 | $111,000 | -37.6% | 31,900 | -5.6% | 0.02% | -34.8% |
Q4 2015 | $178,000 | – | 33,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |